INDICATIONS AND USAGE Isosorbide mononitrate tablets, USP are indicated for the prevention and treatment of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Actavis Pharma, Inc.
ISOSORBIDE MONONITRATE tablets, USP are available as follows: 10 mg â€” Each blue, round, tablet imprinted with and 631 on one side and scored on the other side, contains 10 mg of
ISOSORBIDE MONONITRATE (diluted), USP. Tablets are supplied in bottles of 100 (NDC 0228-2631-11). 20 mg â€” Each blue, round, tablet imprinted with and 620 on one side and scored on the other side, contains 20 mg of
ISOSORBIDE MONONITRATE (diluted), USP. Tablets are supplied in bottles of 100 (NDC 0228-2620-11). Dispense in tight containers as defined in the USP. Store at 25ÂºC (77ÂºF); excursions permitted to 15Âº to 30ÂºC (59Âº to 86ÂºF). Keep tightly closed. Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA 40-9190 Revised â€” January 2015 596e94e8-figure-02 596e94e8-figure-03
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site